2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.15+$0.05 (+4.55%)
Price as of Nov 12, 2026 8:33 AM EST- $34.1MMarket Cap
- -27.63%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.15+$0.05 (+4.55%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.10 | ||
Change | $0.00 (0.00%) | ||
Open | $1.11 | ||
High | $1.15 | ||
Low | $1.09 | ||
Previous Close | $1.10 | ||
Volume | 283,803 | ||
30-Day Average Volume | 312,121 | ||
1-Week Change | -17.29% | ||
1-Month Change | -41.80% | ||
1-Year Change | -27.63% | ||
3-Year Change | -83.97% | ||
5-Year Change | -92.48% | ||
Fundamentals | |||
Shares Outstanding | 31.0M | ||
Total Assets | $21.5M | ||
Market Cap | $34.1M | ||
Enterprise Value | $17.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.7M | ||
Net Working Capital | $15.8M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue